Physician profile
Jason E Cox
NPI 1720016710
$1,036.00
in general payments reported to CMS, 2019-2025
16 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $14.40 · 2021: $42.59 · 2022: $57.43 · 2023: $183 · 2024: $293 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $178.16 | 2024-2025 | Xifaxan |
| Pfizer INC. | $169.07 | 2019-2025 | |
| Ucb, INC. | $165.76 | 2023-2025 | Briviact, Fintepla |
| Janssen Pharmaceuticals, INC | $114.68 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $100.81 | 2019-2024 | Eliquis |
| Novartis Pharmaceuticals Corporation | $42.14 | 2019 | |
| Smith+Nephew, INC. | $38.87 | 2024 | Collagenase Santyl |
| Glaxosmithkline, LLC. | $35.91 | 2019 | |
| Dexcom, INC. | $30.88 | 2025 | Dexcom G6 Transmitter |
| Melinta Therapeutics, LLC | $28.81 | 2019-2020 | |
| Allergan, INC. | $28.70 | 2019 | |
| Abbvie INC. | $28.07 | 2021-2023 | Dalvance |
| Merck Sharp & Dohme LLC | $24.42 | 2023 | Verquvo |
| Abbott Laboratories | $20.56 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.16 | 2023 | Rebyota |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $14.00 | 2025 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.